Agendia
Rene Bernards is the Founder and Chief Scientific Officer at Agendia, where Rene developed the first molecular diagnostic gene expression profile for recurrence of breast cancer. With over 30 years of experience in the field, Bernards is currently a Professor of Molecular Carcinogenesis at NKI and previously held positions at Massachusetts General Hospital and Whitehead Institute. Rene holds a PhD in Molecular Biology from Leiden University and an M.Sc in Molecular Biology from the University of Amsterdam.
This person is not in any offices
Agendia
Agendia is the only molecular diagnostics company focused solely on breast cancer. With their groundbreaking genomic testing, they generate reliable and meaningful clinical data about the unique biology of a woman’s breast cancer.